These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 329981

  • 21. Phase 1-11 study of DTIC and cyclocytidine in disseminated malignant melanoma.
    Samson MK, Baker LH, Izbicki RM, Ratanatharathorn V.
    Cancer Treat Rep; 1976 Sep; 60(9):1369-71. PubMed ID: 65223
    [Abstract] [Full Text] [Related]

  • 22. Combination chemotherapy with DTIC (NSC-45388) in advanced malignant melanoma, soft tissue sarcomas, and Hodgkin's disease.
    Beretta G, Bonadonna G, Bajetta E, Tancini G, De Lena M, Azzarelli A, Veronesi U.
    Cancer Treat Rep; 1976 Feb; 60(2):205-11. PubMed ID: 769975
    [Abstract] [Full Text] [Related]

  • 23. Use of methyl-CCNU and procarbazine in advanced malignant melanoma resistant to DTIC therapy.
    Didolkar MS, Baffi RR, Catane R, Kaufman J, Holyoke ED.
    Cancer Treat Rep; 1977 Dec; 61(9):1738-9. PubMed ID: 597824
    [No Abstract] [Full Text] [Related]

  • 24. [Chemotherapy of malignant melanoma. Results of a controlled clinical trial comparing vincristine + dacarbazin (DTIC) with and without duborimycin (author's transl)].
    Chauvergne J, Clavel B, Klein T, Pommatau E.
    Bull Cancer; 1978 Dec; 65(2):107-9. PubMed ID: 359067
    [Abstract] [Full Text] [Related]

  • 25. A comparative clinical trial evaluating the combination of adriamycin, DTIC, and vincristine, the combination of actinomycin D, cyclophosphamide, and vincristine, and a single agent, methyl-CCNU, in advanced sarcomas.
    Creagan ET, Hahn RG, Ahmann DL, Edmonson JH, Bisel HF, Eagan RT.
    Cancer Treat Rep; 1976 Sep; 60(9):1385-7. PubMed ID: 189922
    [No Abstract] [Full Text] [Related]

  • 26. [Treatment of metastasising melanoma with a combination of cytostatic agents (author's transl)].
    Kleeberg UR, Schreml W.
    Dtsch Med Wochenschr; 1976 Jun 04; 101(23):890-4. PubMed ID: 1269431
    [Abstract] [Full Text] [Related]

  • 27. Phase I evaluation of DTIC (NSC-45388) and other studies in malignant melanoma in the Central Oncology Group.
    Johnson RO, Metter G, Wilson W, Hill G, Krementz E.
    Cancer Treat Rep; 1976 Feb 04; 60(2):183-7. PubMed ID: 769971
    [Abstract] [Full Text] [Related]

  • 28. Phase II study of mitolactol and semustine combination chemotherapy for advanced malignant melanoma.
    Creagan ET, Ahmann DL, Schutt AJ, Green SJ.
    Cancer Treat Rep; 1982 Jun 04; 66(6):1425-6. PubMed ID: 7083244
    [Abstract] [Full Text] [Related]

  • 29. Chemoimmunotherapy for disseminated malignant melanoma: a prospective randomized study.
    Ramseur WL, Richards F, Muss HB, Rhyne L, Cooper MR, White DR, Stuart JJ, Spurr CL.
    Cancer Treat Rep; 1978 Jul 04; 62(7):1085-7. PubMed ID: 356970
    [Abstract] [Full Text] [Related]

  • 30. Combined DTIC and cis-dichlorodiammineplatinum(II) therapy for patients with disseminated melanoma: a Northern California Oncology Group study.
    Friedman MA, Kaufman DA, Williams JE, Resser KJ, Rosenbaum EH, Cohen RJ, Glassberg AB, Blume MR, Gershow J, Chan EY.
    Cancer Treat Rep; 1979 Mar 04; 63(3):493-5. PubMed ID: 371802
    [No Abstract] [Full Text] [Related]

  • 31. [Dimethyl-triazeno-imidazole-carboxamide (DTIC) in combination chemotherapy for childhood neuroblastoma (author's transl)].
    Mutz ID, Urban CE.
    Wien Klin Wochenschr; 1978 Dec 22; 90(24):867-70. PubMed ID: 741754
    [Abstract] [Full Text] [Related]

  • 32. Eastern Cooperative Oncology Group studies with DTIC (NSC-45388).
    Carbone PP, Costello W.
    Cancer Treat Rep; 1976 Feb 22; 60(2):193-8. PubMed ID: 769973
    [Abstract] [Full Text] [Related]

  • 33. Chemotherapy of disseminated malignant melanoma with imidazol carboxamide (DTIC) and cyclophosphamide. Preliminary results.
    Rudolf Z, Plesnicar S.
    Anticancer Res; 1982 Feb 22; 2(1-2):37-9. PubMed ID: 7051959
    [Abstract] [Full Text] [Related]

  • 34. Combination chemotherapy in disseminated melanoma and other solid tumors in adults.
    Gerner RE, Moore GE, Dickey C.
    Oncology; 1975 Feb 22; 31(1):22-30. PubMed ID: 1099501
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of 1-(2-chloroethyl-3-4-methylcyclohexyl)-1-nitrosourea (methyl-CCNU, NSC 95441) versus combined imidazole carboxamide (NSC 45338) and vincristine (NSC 67574) in palliation of disseminated malignant melanoma.
    Ahmann DL, Hahn RG, Bisel HF.
    Cancer; 1974 Mar 22; 33(3):615-8. PubMed ID: 4131357
    [No Abstract] [Full Text] [Related]

  • 36. cis-Dichlorodiammineplatinum(II) and DTIC in malignant melanoma.
    Karakousis CP, Getaz EP, Bjornsson S, Henderson ES, Irequi M, Martinez L, Ospina J, Cavins J, Preisler H, Holyoke E, Holtermann O.
    Cancer Treat Rep; 1979 Mar 22; 63(11-12):2009-10. PubMed ID: 393386
    [Abstract] [Full Text] [Related]

  • 37. Combination cytotoxic chemotherapy with CCNU, procarbazine, and vincristine in disseminated cutaneous malignant melanoma: 3 years, followup.
    Carmo-Pereira J, Costa FO, Pimentel P, Henriques E.
    Cancer Treat Rep; 1980 Jan 22; 64(1):143-5. PubMed ID: 7379048
    [Abstract] [Full Text] [Related]

  • 38. Combination chemotherapy of malignant melanoma with imidazole carboxamide, BCNU and vincristine.
    Cohen SM, Greenspan EM, Ratner LH, Weiner MJ.
    Cancer; 1977 Jan 22; 39(1):41-4. PubMed ID: 832250
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.